For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

To further muddy the waters, card reviews and advertising generally label the insurance as primary or secondary. Before applying for a card, it’s worth knowing the differences between these ...

Emerging antidiabetic drugs sodium-glucose cotransporter 2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1RAs), and dipeptidyl peptidase-4 inhibitors (DPP-4i) have demonstrated ...

Can include rhythm, melody, harmony, dynamics, texture, timbre and structure. of the music such as their melody close melodyDifferent pitched notes played one after another making a tune., ...

A recent study combining genome-wide RBP profiling and RNA secondary structure profiling shows that RBP binding sites tend to be more single-stranded (Gosai et al., 2015). Interestingly, a nuclear PIP ...